The Subventricular Zone: A Key to Unlocking Neurological Treatments
en-GBde-DEes-ESfr-FR

The Subventricular Zone: A Key to Unlocking Neurological Treatments

04/03/2025 Compuscript Ltd


This recently published exploration into the subventricular zone (SVZ) highlights its critical role in neural regeneration, neurodegenerative diseases, and glioblastoma multiforme (GBM). The SVZ, a neurogenic hub of the adult brain, harbors neural stem cells (NSCs) and neural progenitor cells (NPCs), influencing brain repair and disease progression.
The SVZ is a dynamic reservoir of neurogenesis, continuously generating new neurons and glial cells essential for brain plasticity and recovery. Its intricate cellular composition, including ependymal cells, astrocytes, and migrating neuroblasts, enables significant contributions to neural injury repair. In cases of brain damage, SVZ-derived cells can migrate to injured regions, differentiating into specialized neural cells, fostering repair and functional restoration.
In the realm of neurodegenerative diseases, the SVZ plays a complex role. Conditions such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD) exhibit alterations in SVZ neurogenesis, impacting disease progression. In AD, amyloid-beta accumulation and tau pathology suppress neural regeneration, while in PD, dopamine depletion disrupts SVZ stem cell function. For HD, increased proliferation in the SVZ is observed, though this fails to counteract the progressive neuronal loss. The potential of stem cell-based therapies targeting the SVZ could offer novel interventions for these devastating conditions.
The connection between SVZ and GBM is particularly striking. The SVZ’s stem cell niche has been implicated in GBM initiation, progression, and resistance to therapy. Glioblastoma cells often originate within or near the SVZ, exploiting its stem cell-like environment to sustain tumor growth and invasiveness. Emerging research suggests that targeting SVZ-related pathways may enhance GBM treatments, potentially overcoming the radioresistance and recurrence that are experienced with conventional therapies.
The therapeutic potential of the SVZ is encouraging, with neural stem cell transplantation, cytokine therapy, and targeted gene interventions emerging as promising strategies. Harnessing the SVZ’s regenerative capacity could revolutionize treatments for brain injuries, neurodegenerative disorders, and aggressive brain tumors. With further advancements, the future of neurology may be shaped by a deeper understanding of the SVZ’s profound impact on brain health and disease.

Funding Information:
Medical Scientific Research Foundation of Guangdong Province, China A2022125
Medical Scientific Research Foundation of Guangdong Province, China A2023486
Medical Research Fund of the Qingyuan People's Hospital 15001019002213
National Natural Science Foundation of China 82203351
Guangdong Basic and Applied Basic Research Foundation of China 2021A1515111095

# # # # #
Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis is placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.
Scopus CiteScore: 7.3
Impact Factor: 6.9

# # # # # #

More information: https://www.keaipublishing.com/en/journals/genes-and-diseases/
Editorial Board: https://www.keaipublishing.com/en/journals/genes-and-diseases/editorial-board/
All issues and articles in press are available online in ScienceDirect (https://www.sciencedirect.com/journal/genes-and-diseases ).
Submissions to Genes & Disease may be made using Editorial Manager (https://www.editorialmanager.com/gendis/default.aspx ).
Print ISSN: 2352-4820
eISSN: 2352-3042
CN: 50-1221/R
Contact Us: editor@genesndiseases.com
X (formerly Twitter): @GenesNDiseases (https://x.com/GenesNDiseases )

# # # # # #
Reference
Kaishu Li, Yin Zheng, Shubing Cai, Zhiming Fan, Junyi Yang, Yuanrun Liu, Shengqi Liang, Meihui Song, Siyuan Du, Ling Qi, The subventricular zone structure, function and implications for neurological disease, Genes & Diseases, Volume 12, Issue 3, 2025, 101398, https://doi.org/10.1016/j.gendis.2024.101398
Kaishu Li, Yin Zheng, Shubing Cai, Zhiming Fan, Junyi Yang, Yuanrun Liu, Shengqi Liang, Meihui Song, Siyuan Du, Ling Qi, The subventricular zone structure, function and implications for neurological disease, Genes & Diseases, Volume 12, Issue 3, 2025, 101398, https://doi.org/10.1016/j.gendis.2024.101398
Attached files
  • The relationship between subventricular zone (SVZ) cells and glioblastoma multiforme (GBM) development.Image link https://ars.els-cdn.com/content/image/1-s2.0-S2352304224001958-gr2_lrg.jpg
  • The relationship between subventricular zone (SVZ) cells and glioblastoma multiforme (GBM) progression. SVZ affects GBM through secretions and signaling pathways (yellow scissors) and promotes its invasion and growth by secreting factors (white scissors).Image link https://ars.els-cdn.com/content/image/1-s2.0-S2352304224001958-gr3_lrg.jpg
  • Comparison of subventricular zone (SVZ) cellular composition between human glioblastoma multiforme (GBM) patients and rodent models.Image link: https://ars.els-cdn.com/content/image/1-s2.0-S2352304224001958-gr1_lrg.jpg
04/03/2025 Compuscript Ltd
Regions: Europe, Ireland, Asia, China
Keywords: Health, Medical, People in health research, Science, Chemistry, Life Sciences

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonials

For well over a decade, in my capacity as a researcher, broadcaster, and producer, I have relied heavily on Alphagalileo.
All of my work trips have been planned around stories that I've found on this site.
The under embargo section allows us to plan ahead and the news releases enable us to find key experts.
Going through the tailored daily updates is the best way to start the day. It's such a critical service for me and many of my colleagues.
Koula Bouloukos, Senior manager, Editorial & Production Underknown
We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet

We Work Closely With...


  • e
  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2025 by AlphaGalileo Terms Of Use Privacy Statement